DK1139101T3 - Immunobestemmelse for C-reaktivt protein - Google Patents

Immunobestemmelse for C-reaktivt protein

Info

Publication number
DK1139101T3
DK1139101T3 DK01303068T DK01303068T DK1139101T3 DK 1139101 T3 DK1139101 T3 DK 1139101T3 DK 01303068 T DK01303068 T DK 01303068T DK 01303068 T DK01303068 T DK 01303068T DK 1139101 T3 DK1139101 T3 DK 1139101T3
Authority
DK
Denmark
Prior art keywords
immunoassay
antibody
antiidiotypic
reactive protein
monoclonal antibody
Prior art date
Application number
DK01303068T
Other languages
English (en)
Inventor
Edward R Scalice
John L Daiss
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DK1139101T3 publication Critical patent/DK1139101T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01303068T 2000-03-31 2001-03-30 Immunobestemmelse for C-reaktivt protein DK1139101T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19395100P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
DK1139101T3 true DK1139101T3 (da) 2006-04-10

Family

ID=22715702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01303068T DK1139101T3 (da) 2000-03-31 2001-03-30 Immunobestemmelse for C-reaktivt protein

Country Status (7)

Country Link
US (1) US6838250B2 (da)
EP (1) EP1139101B1 (da)
JP (1) JP5031148B2 (da)
AT (1) ATE314653T1 (da)
DE (1) DE60116172T2 (da)
DK (1) DK1139101T3 (da)
ES (1) ES2254330T3 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316232A (pt) 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
WO2006004039A1 (ja) * 2004-07-02 2006-01-12 Sanwa Kagaku Kenkyusho Co., Ltd. 免疫測定装置及び方法
KR20080006617A (ko) 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
US20060246522A1 (en) * 2005-04-28 2006-11-02 Bhullar Balwant S C-reactive protein immunoassay and method
US20090246795A1 (en) * 2005-12-22 2009-10-01 Rohm Co., Ltd. Immunoassay device and method
US8383350B1 (en) 2006-12-20 2013-02-26 Merck Sharp & Dohme Corp. Assay for detection of IL-10 antibodies
CA2696210A1 (en) 2007-08-28 2009-03-12 Abbott Biotechnology Ltd. Compositions and methods comprising binding proteins for adalimumab
JP4970217B2 (ja) * 2007-11-07 2012-07-04 株式会社東芝 物質の測定方法
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
JP5265257B2 (ja) * 2008-06-30 2013-08-14 富士フイルム株式会社 犬ｃｒｐ及び人ｃｒｐを認識する抗体
WO2010056682A2 (en) 2008-11-11 2010-05-20 Prometheus Laboratories Inc. Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
JP5807300B2 (ja) * 2008-11-18 2015-11-10 株式会社シノテスト 試料中のｃ反応性蛋白質の測定方法及び測定試薬
NZ595471A (en) 2009-04-14 2014-01-31 Nestec Sa Inflammatory bowel disease prognostics
CA2766157A1 (en) 2009-06-25 2010-12-29 Hua Gong Methods for diagnosing irritable bowel syndrome
WO2011060098A1 (en) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis
EP4349868A3 (en) * 2010-05-14 2024-08-28 The Board of Trustees of the Leland Stanford Junior University Humanized and chimeric monoclonal antibodies to cd47
JP5960707B2 (ja) 2010-10-18 2016-08-02 ネステク ソシエテ アノニム 抗薬物抗体アイソタイプを決定するための方法
ES2530175T3 (es) 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
EP2702076A1 (en) 2011-04-29 2014-03-05 Bristol-Myers Squibb Company Ip-10 antibody dosage escalation regimens
WO2012154987A1 (en) 2011-05-10 2012-11-15 Nestec Sa Methods of disease activity profiling for personalized therapy management
EP2769321B1 (en) 2011-10-21 2016-06-01 Nestec S.A. Methods for improving inflammatory bowel disease diagnosis
EP2797952B1 (en) 2011-12-28 2019-02-27 ImmunoQure AG Method of providing monoclonal auto-antibodies with desired specificity
ES2638971T3 (es) 2012-10-05 2017-10-24 Nestec S.A. Métodos para predecir y monitorizar la cicatrización de la mucosa
SG11201509371XA (en) 2013-05-24 2015-12-30 Nestec Sa Pathway specific markers for diagnosing irritable bowel syndrome
US10112995B2 (en) 2013-07-03 2018-10-30 Immunoqure Ag Human anti-IFN-α antibodies
EP3066469B1 (en) 2013-11-05 2017-10-11 Roche Diagnostics GmbH A method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto
CA2932571A1 (en) 2013-12-03 2015-06-11 Nestec S.A. Methods for predicting post-operative recurrence of crohn's disease
WO2015166461A1 (en) 2014-05-01 2015-11-05 Nestec S.A. Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
JP2018504584A (ja) 2014-12-02 2018-02-15 ネステク ソシエテ アノニム 過敏性腸疾患患者を治療するためのベドリズマブの投与計画を確立する方法
AU2016349703A1 (en) 2015-11-06 2018-11-01 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
CN108279229B (zh) * 2017-01-05 2024-02-27 深圳市帝迈生物技术有限公司 一种全血crp检测装置
EP3695229A1 (en) 2017-10-10 2020-08-19 Prometheus Biosciences, Inc. Methods for monitoring vedolizumab treatment
CN112051403A (zh) * 2020-08-27 2020-12-08 武汉生之源生物科技股份有限公司 C反应蛋白化学发光免疫检测试剂盒及其制备方法和应用
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
DE3685377D1 (de) * 1985-07-22 1992-06-25 Abbott Lab Fluoreszenz-polarisation-immunotest und reagens zur messung von c-reaktivem protein.
JPH04505857A (ja) 1989-06-27 1992-10-15 ラッシュ―プレズビティリアン―セント　ルークス　メディカル　センター Ｃ反応性蛋白質に対するモノクローナル抗体
JP3174402B2 (ja) * 1992-06-08 2001-06-11 三洋化成工業株式会社 競合法による免疫測定法および測定用キット
JPH10282098A (ja) * 1997-04-11 1998-10-23 Matsushita Electric Ind Co Ltd 蛍光免疫測定法

Also Published As

Publication number Publication date
JP2002040024A (ja) 2002-02-06
EP1139101A2 (en) 2001-10-04
EP1139101A3 (en) 2002-05-15
EP1139101B1 (en) 2005-12-28
US20020142356A1 (en) 2002-10-03
EP1139101A9 (en) 2002-03-20
ATE314653T1 (de) 2006-01-15
JP5031148B2 (ja) 2012-09-19
HK1038069A1 (en) 2002-03-01
US6838250B2 (en) 2005-01-04
ES2254330T3 (es) 2006-06-16
DE60116172T2 (de) 2006-08-03
DE60116172D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
DE60116172D1 (de) Immunoassay für C-reaktives Protein
DE502004011867D1 (de) Analytischer Sandwichtest zur Bestimmung von NT-proBNP
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
TW200516083A (en) Methods for making dual specificity antibodies
NZ547157A (en) Interferon Alpha Antibodies and their uses
ES2184660T1 (es) Anticuerpos humanizados que secuestran peptidos abeta.
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
DE60334141D1 (de) VERÄNDERUNG VON FcRn-BINDUNGSAFFINITÄTEN ODER VON SERUMHALBWERTSZEITEN VON ANTIKÖRPERN MITTELS MUTAGENESE
WO2004025248A3 (en) Antibody pair screening methods
WO1998023955A3 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
PT1308507E (pt) Anticorpo monoclonal anti-núcleo de hcv
DE60222816D1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
DK1297017T3 (da) Sammensætninger og fremgangsmåder med monoklonale og polyklonale antistoffer, der er specifikke for T-cellesubpopulationer
MX9401112A (es) Preparacion de conjugados de fotoproteina y metodos para utilizar los mismos.
DE50210021D1 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
ATE474226T1 (de) Taxol-immunoassay
WO2023196658A3 (en) Antibody compositions and optimization methods
ATE410693T1 (de) Hcv-test
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
ES2061324T3 (es) Complejo aglutinante como reactivo de identificacion de grupo sanguineo.
WO2002076406A3 (en) Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them